Endocrine and amine responses to D,L-fenfluramine in normal subjects
- PMID: 1686811
- DOI: 10.1016/0165-1781(91)90083-2
Endocrine and amine responses to D,L-fenfluramine in normal subjects
Abstract
To investigate indirectly the central neurotransmitter mechanisms of D,L-fenfluramine-induced hormone release, prolactin, adrenocorticotropic hormone, cortisol, growth hormone, 3-methoxy-4-hydroxyphenylglycol (MHPG), homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5HIAA) responses to D,L-fenfluramine (60 mg, oral) were examined in a single-blind, placebo-controlled trial in 14 normal subjects. As compared with placebo, D,L-fenfluramine significantly increased both prolactin and cortisol. There was a significant correlation between the cortisol and prolactin responses. HVA levels were also significantly increased, but there were no changes in MHPG or 5HIAA. The elevation in HVA significantly correlated with increases in both prolactin and cortisol. These findings are consistent with recent animal studies suggesting that D,L-fenfluramine-induced prolactin and cortisol release may be mediated, at least in part, by catecholaminergic systems.
Similar articles
-
Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.Neuropsychopharmacology. 1996 Dec;15(6):595-607. doi: 10.1016/S0893-133X(96)00133-9. Neuropsychopharmacology. 1996. PMID: 8946434 Clinical Trial.
-
Plasma prolactin, adrenocorticotrophic hormone and cortisol after administration of d-fenfluramine or placebo to healthy subjects.Int Clin Psychopharmacol. 1993 Summer;8(2):123-8. doi: 10.1097/00004850-199300820-00008. Int Clin Psychopharmacol. 1993. PMID: 8393895 Clinical Trial.
-
Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.Br J Psychiatry. 1992 Oct;161:517-21. doi: 10.1192/bjp.161.4.517. Br J Psychiatry. 1992. PMID: 1393339
-
The fenfluramine challenge test in the affective spectrum: a possible marker of endogeneity and severity.Pharmacopsychiatry. 1988 Jan;21(1):9-14. doi: 10.1055/s-2007-1014638. Pharmacopsychiatry. 1988. PMID: 3283785 Review.
-
Serotonin receptors.Monogr Neural Sci. 1984;10:158-81. doi: 10.1159/000408388. Monogr Neural Sci. 1984. PMID: 6366527 Review. No abstract available.
Cited by
-
Effects of medications on cerebral blood flow in late-life depression.Curr Psychiatry Rep. 2002 Feb;4(1):51-8. doi: 10.1007/s11920-002-0013-x. Curr Psychiatry Rep. 2002. PMID: 11814396 Review.
-
Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects.Neuropsychopharmacology. 2010 Jan;35(2):435-44. doi: 10.1038/npp.2009.148. Neuropsychopharmacology. 2010. PMID: 19776731 Free PMC article. Clinical Trial.
-
Clomipramine-induced serum prolactin as a marker for serotonin and dopamine turnover: results of an open label study.Eur Arch Psychiatry Clin Neurosci. 2011 Dec;261(8):567-73. doi: 10.1007/s00406-011-0201-y. Epub 2011 Mar 15. Eur Arch Psychiatry Clin Neurosci. 2011. PMID: 21404115
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials